Source: MedicalMarketing& Media

Havas: Havas launches creator-led docuseries 'Shape Shifting' backed by doctors and scientists

The series tackles the 'GLP-1 revolution,' created to educate consumers about the medication's potential uses and side effects.

Read full article »
Est. Annual Revenue
$1.0-5.0B
Est. Employees
10-50K
Yannick Bollore's photo - Chairman & CEO of Havas

Chairman & CEO

Yannick Bollore

CEO Approval Rating

78/100

Read more